24 Hour Ambulatory Blood Pressure Monitoring In Patients With Chronic Kidney Disease

Chintal   Vyas; Animesh A Shah; Anjali B Patel; Monila N  Patel; Jyoti Vora

doi:10.48165/ijabms.2022.243828

Authors

Chintal Vyas Associate Professor Department of Medicine, SVP hospital, SMT NHL Municipal Medical College, Ellisbridge, Ahmedabad
Animesh A Shah MD (Medicine) 2nd Year Resident DNB Gastroenterology Gleneagles Global Hospital,Maharashtra
Anjali B Patel (MBBS) 2nd Year Resident MD General Medicine Department of Medicine, SVP hospital, SMT NHL Municipal Medical College, Ellisbridge, Ahmedabad
Monila N Patel (Medicine) Head Of Unit Department of Medicine, SVP hospital,SMT NHL Municipal Medical College, Ellisbridge, Ahmedabad
Jyoti Vora MD (Medicine) Associate Professor Department of Medicine, SVP hospital,SMT NHL Municipal Medical College, Ellisbridge, Ahmedabad

DOI:

https://doi.org/10.48165/ijabms.2022.243828

Keywords:

Chronic Kidney Disease, Hypertension Dialysis, Ambulatory Blood Pressure, Diurnal Variation

Abstract

Background and aims: Chronic Kidney Disease (CKD) And Hypertension(HTN) Are Associated With Each Other Invariably And Each Can Cause Or Aggravate The Other.Hypertension Is A Strong Independent Risk Factor For ESRD And Contributes To The Disease Itself, Or Most Commonly, To Its Progression.24 Hour Ambulatory Blood Pressure Monitoring (ABPM) Is Superior To Clinic BP Monitoring In Predicting The Risk In Hypertensive CKD Patients The Aim Of This Study Was To Review The Results Of ABPM In CKD Patients Which Can Guide In Changing The Antihypertensive Therapy . Material and Methods: This Prospective Observational Study Having 63 Patients. All The _{Patients Fulfilling The Criteria Of CKD According To The KDIGO Guidelines}And Above 18 Years Of Age Were Included In This Study Whose 24 Hour Ambulatory Blood Pressure Was Measured.Detailed History, Clinical Examination And Relevant Investigations Were Recorded Comparisons Of Various ABPM Characteristics WERE Done And P Value <0.005 Was Considered Significant. Results: Out Of 63 Patients (M:38,F:25)Maximum Patients (25.39%)Were In Age Group 61-70 Years (M:61-70,F:41-45).51(80.95%)Patients Were On Dialysis And 12 (19.04%)Patients Were Not On Dialysis. In This Study 57 Patients Had Hypertension, 44 Had DM,16 Had IHD.In This Study 2(3.17%) Patients Were CKD Stage I,5(7.93%) Were Stage II,1(1.58%) Was Stage lll, 6(9.52%) Were Stage IV And 49 (77.77%) Were Stage V.Out Of Total 16(25.39%) Patients Were Dippers ,21 (33.33%) Were Non Dippers, 21(33.33%) Were Reverse Dippers And 5 (7.93%) Were Extreme Dippers..Mean ABPM Systolic BP ,Mean ABPM Diastolic BP,Mean PTA Systolic BP,Mean Arterial Pressure Were Significantly Higher In Male Patients which were On Dialysis Than Patient Not On Dialysis. Conclusion: ABPM is Superior Than Clinical Bp Monitoring In Predicting The Future Communications In CKD Patients Especially PTE,HBI MAP And Other Parameter To Guide To Formulate Treatment Protocol Identifying Such Patients Of Hypertension In Earlier Stages Of CKD,Helped In Morbidity Outcomes While Identifying In Later Stages Of CKD Helped In Mortality Benefits.

References

Cunha C, Pereira S, Fernandes JC, Dias VP. 24-hour ambulatory blood pressure monitoring in chronic kidney disease and its influence on treatment. Portuguese Journal of Nephrology & Hypertension. 2017 Mar;31(1):31-6.

Morgado E, Neves PL. Hypertension and chronic kidney disease: cause and consequence-therapeutic considerations. Antihypertensive drugs. 2012 Mar 28;1:45-66.

Ravera M, Re M, Deferrari L, Vettoretti S, Deferrari G. Importance of blood pressure control in chronic kidney disease. Journal of the American Society of Nephrology. 2006 Apr 1;17(4 suppl 2):S98-103.

Abraham G, Arun KN, Gopalakrishnan N, Renuka S, Pahari DK, Deshpande P, Isaacs R, Chafekar DS, Kher V, Almeida AF, Sakhuja V. Management of hypertension in chronic kidney disease: consensus statement by an expert panel of Indian nephrologists. The Journal of the Association of Physicians of India. 2017 Feb;65(2 Suppl):6-22.

Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Pede S, Porcellati C. Ambulatory pulse pressure: a potent predictor of total cardiovascular risk in hypertension. Hypertension. 1998 Dec;32(6):983-8.

Kario K. Morning surge in blood pressure and cardiovascular risk: evidence and perspectives. Hypertension. 2010 Nov 1;56(5):765-73.

Choudhary L, Gupta P, Gupta A, Saxena P, Chaurasia AK. 24 hour ambulatory blood pressure monitoring and left ventricular ejection fraction-prognostic markers in chronic kidney disease. Int J Adv Med. 2016 Apr;3(2):402-8.

Dolan E, Stanton A, Thijs L, Hinedi K, Atkins N, McClory S, Hond ED, McCormack P, Staessen JA, O’Brien E. Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: the Dublin outcome study. Hypertension. 2005 Jul 1;46(1):156-61.

O’Brien E, Parati G, Stergiou G. Ambulatory blood pressure measurement: what is the international consensus?. Hypertension. 2013 Dec;62(6):988-94.

Tientcheu D, Ayers C, Das SR, McGuire DK, de Lemos JA, Khera A, Kaplan N, Victor R, Vongpatanasin W. Target organ complications and cardiovascular events associated with masked hypertension and white-coat hypertension: analysis from the Dallas Heart Study. Journal of the American College of Cardiology. 2015 Nov 17;66(20):2159-69.

Siu AL, US Preventive Services Task Force*. Screening for high blood pressure in adults: US Preventive Services Task Force recommendation statement. Annals of internal medicine. 2015 Nov 17;163(10):778-86.

Eknoyan G. Chronic kidney disease definition and classification: no need for a rush to judgment. Kidney international. 2009 May 2;75(10):1015-8.

Agarwal R, Andersen MJ. Prognostic importance of ambulatory blood pressure recordings in patients with chronic kidney disease. Kidney international. 2006 Apr 1;69(7):1175-80.

Iimuro S, Imai E, Watanabe T, Nitta K, Akizawa T, Matsuo S, Makino H, Ohashi Y, Hishida A, Chronic Kidney Disease Japan Cohort Study Group. Clinical correlates of ambulatory BP monitoring among patients with CKD. Clinical Journal of the American Society of Nephrology. 2013 May 7;8(5):721-30.

Kasper D, Fauci A, Hauser S, Longo D, Jameson J, Loscalzo J. Harrison's principles of internal medicine, 20e. New York, NY, USA:: Mcgraw-hill; 2015.

Iwai T, Miyazaki M, Yamada G, Nakayama M, Yamamoto T, Satoh M, Sato H, Ito S. Diabetes mellitus as a cause or comorbidity of chronic kidney disease and its outcomes: the Gonryo study. Clinical and experimental nephrology. 2018 Apr;22(2):328-36.

Amoako YA, Laryea DO, Bedu-Addo G, Andoh H, Awuku YA. Clinical and demographic characteristics of chronic kidney disease patients in a tertiary facility in Ghana. The Pan African Medical Journal. 2014;18.

Pickering TG. The clinical significance of diurnal blood pressure variations. Dippers and nondippers. Circulation. 1990 Feb;81(2):700-2.

)Angeli F, Gentile G, Trapasso M, Verdecchia P, Reboldi G. Role and prognostic value of individual ambulatory blood pressure components in chronic kidney disease. Journal of human hypertension. 2018 Sep;32(8):625-32.

Becker GJ, Wheeler DC, De Zeeuw D, Fujita T, Furth SL, Holdaas H, Mendis S, Oparil S, Perkovic V, Rodrigues CI, Sarnak MJ. Kidney disease: Improving global outcomes (KDIGO) blood pressure work group. KDIGO clinical practice guideline for the management of blood pressure in chronic kidney disease. Kidney International Supplements. 2012 Dec;2(5):337-414.

Alhamid N, Alterky H, Othman MI. Renal artery embolization for managing uncontrolled hypertension in a kidney transplant candidate. Avicenna journal of medicine. 2013 Jan;3(1):23.

Luther JM, Golper TA. Blood pressure targets in hemodialysis patients. Kidney international. 2008 Mar 2;73(6):667-8.